Morning Movers
Watch us on YouTube Live at 8:30AM EST

Travel Stocks – Lower as a group with the overall market in early trading as increasing covid cases globally has investors heading to the sidelines again this morning, Carnival Cruise became the first to resume sailings from Port Of New Orleans over the weekend. Casinos remain on watch after the Macau related negativity we saw last week. CCL, RCL, NCLH, MGM, LVS, WYNN

BA.NY -2.23%
Boeing Co – Under pressure in early trading despite announcing it has secured a $1.62B US Air Force contract to repair the guidance kit of the U.S. Air Force’s Minuteman III intercontinental ballistic missile.

Vaccine Stocks – Lower as a group premarket despite multiple mixed news catalysts this morning, PFE shares are in focus after the company released positive trial results of its COVID-19 vaccine in children ages 5 to 11 years. Regulators are expected to approve a third Pfizer shot for US citizens 65 and older this week. This comes after an FDA advisory panel late last week rejected the need for such a move outside of “high-risk” groups. PFE, BNTX, MRNA, JNJ, AZN

SDC.NQ 11.34%
SmileDirect Club – The most active among the highly-shorted stocks this morning, SDC was the most talked about stock on Reddit’s Wallstreetbets, data aggregated on showed. About 34% of the teeth alignment firm’s float is sold short, S3 Partners said on Friday, adding that the co is a strong squeeze candidate.

Crypto Stocks – Lower along overall prices this morning, very volatile 24 hrs for BTC prices now testing recent lows of $44000. El Salvador said it has bought an additional 150 bitcoins on this most recent dip as BTC drops by nearly $4,000. ETH also sliding below recent lows back toward the $3000 level. COIN, BTBT, FTFT, MSTR, SOS, MARA, RIOT

AMC.NY -7.29%
AMC Entertainment – Down more than 7% premarket adding to Friday’s sharp declines, no news, higher premarket volume.

ZIVO.NQ 146.80%
Zivo Biosciences – Low-float (6m) micro-cap premarket runner with no news, increased online chatter.

VSTM.NQ 21.74%
Verastem Inc – Trading higher after announcing a new partnership with Amgen Inc to evaluate its experimental drug, VS-6766, in combination with the biotech co’s Lumakras in treating patients with non-small cell lung cancer, a type of lung cancer.

CRVS.NQ 3.01%
Corvus Pharmaceuticals – Very strong Friday, positive cancer related data out late last week, multi-day mover. Another relatively low-float stock, 38m free float.

Leave a Reply

Your email address will not be published.